Legal Representation
Attorney
Bryce J. Maynard
USPTO Deadlines
Next Deadline
2033 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 4, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Feb 4, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 17, 2024 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Oct 7, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 2, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 15, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Mar 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 9, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
Additional Information
Design Mark
The mark consists of the stylized wording CYLEMBIO with a circle made up of ten circles of varying sizes in a circular pattern above the letter "I".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005